Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8.
J Exp Med
2005
202
11
1575-85
Broad degradation of proapoptotic proteins with the conserved Bcl-2 homology domain 3 during infection with Chlamydia trachomatis.
Infect Immun
2005
73
3
1399-403
Engagement of Toll-like receptors by mycoplasmal superantigen: downregulation of TLR2 by MAM/TLR4 interaction.
Cell Microbiol
2005
7
6
789-97
The mucosal adjuvant macrophage-activating lipopeptide-2 directly stimulates B lymphocytes via the TLR2 without the need of accessory cells.
J Immunol
2005
174
10
6308-13
Toll-like receptor-dependent activation of several human blood cell types by protamine-condensed mRNA.
Eur J Immunol
2005
35
5
1557-66
Mycobacterium tuberculosis regulates CD1 antigen presentation pathways through TLR-2.
J Immunol
2005
175
3
1758-66
Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
J Am Soc Nephrol
2005
16
12
3592-601
Embryonic endothelial progenitor cells expressing a broad range of proangiogenic and remodeling factors enhance vascularization and tissue recovery in acute and chronic ischemia.
FASEB J
2005
19
11
1576-8
NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145.
J Exp Med
2005
201
2
211-20
Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney.
J Clin Invest
2005
115
10
2894-903